Medical News

RSS

Survival rate is improving in HER2 positive breast cancer patients

Trends indicate that survival is improving in patients with metastatic breast cancer, especially in those patients whose tumours are described as being HER2 (human epidermal growth factor receptor-2) positive, a surgical oncologist will say today (Friday 26 March) at the seventh European Breast Cancer Conference.

26 Mar 2010

U.S. DEA rules prevent nursing home patients in severe pain from receiving needed medication

U.S. Drug Enforcement Administration's rules and procedures are seriously delaying and in some cases preventing nursing home patients from getting the pain medication they need.

26 Mar 2010

OHA expresses strong support for creation of committee to address hospital working capital deficits

Today, the Ontario Hospital Association expressed disappointment that the 2010 Ontario Budget did not provide the hospital sector with the 2% increase to base operating funding recommended for 2010/11, but also expressed its strong support for the creation of a committee to address hospital working capital deficits and the Budget's reiteration of the government's intent to proceed with a review of the Public Hospitals Act.

26 Mar 2010

Abnormality on chromosome 17 helps detect breast cancer tumour's response to anthracyclines

British researchers have discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics. The study has found that an abnormality on chromosome 17, called CEP17, is not only associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumour will respond to anthracyclines. The research will be presented at the European Breast Cancer Conference (EBCC7) Thursday 25th March.

26 Mar 2010

Treatment with beta-blockers can help reduce spread of cancer in patients with breast tumours

Treatment with beta-blockers can help reduce the spread of cancer in patients with breast tumours, a researcher will tell the seventh European Breast Cancer Conference in Barcelona today (Friday).

26 Mar 2010

Avid, Cardinal Health partner to detect Alzheimer's disease in living patients

Currently, Alzheimer's disease cannot be definitively diagnosed until after death, when a brain autopsy is performed on a patient and evidence of beta-amyloid plaque deposits in the brain – which are a characteristic pathology of the disease – can be found. Accurate diagnosis during life can be challenging, particularly in the early stages of Alzheimer's, when symptoms are mild and non-definitive. However, Avid Radiopharmaceuticals, Inc. and Cardinal Health are working together to change that.

26 Mar 2010

American Academy of Actuaries to work with regulatory authorities to enhance quality of care

With the enactment of health care reform legislation yesterday, the American Academy of Actuaries said the successful implementation of this and forthcoming reconciliation legislation will require coordinated efforts to ensure that the regulatory development process accomplishes the intended goals of reform.

26 Mar 2010

Evaluating potential of Ampligen and TLR3 agonists as cancer immunotherapeutics

Hemispherx Biopharma, Inc., announced today the publication of an editorial entitled "TLR3 agonists as immunotherapeutic agents," published in the March 15, 2010 edition of Immunotherapy (2010) 2(2), 137-140, co-authored by Jonathan S. Berek, MD, Chairman, Stanford University School of Medicine Department of Obstetrics and Gynecology, and Christopher F. Nicodemus, MD, Chairman and Chief Scientific Officer, Advanced Immune Therapeutics, Inc., and HEB Consultant.

26 Mar 2010

FDA Advisory Committee to review VIVUS' NDA for Qnexa

VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.

26 Mar 2010

Alere WCH partners with Monica Healthcare

Alere Health, LLC, a leader in personal health support solutions, today announced a partnership between the Alere® Women's & Children's Health Division and UK-based Monica Healthcare Ltd, developers of a groundbreaking wireless, wearable fetal-maternal monitor.

26 Mar 2010

BLS acquires AMPAKINE compounds from Cortex Pharmaceuticals

Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL, has acquired certain AMPAKINE® compounds, including associated intellectual property, from Cortex Pharmaceuticals, Inc. for use in the field of respiratory depression, a brain-mediated breathing disorder.

26 Mar 2010

New devices pave way for applications in cardiology and neurology

A team of cardiologists, materials scientists, and bioengineers have created and tested a new type of implantable device for measuring the heart's electrical output that they say is a vast improvement over current devices. The new device represents the first use of flexible silicon technology for a medical application.

26 Mar 2010

Pravastatin benefits elderly carriers of KIF6 gene variant with prior vascular disease

Celera Corporation today announced the publication of data reporting that elderly (over age 70) carriers of the KIF6 gene variant with prior vascular disease received significant benefit from pravastatin (Pravachol®) therapy. Previous research has shown that a variant of the KIF6 gene, a member of the molecular motor protein kinesin family, is associated with up to a 55% increased risk of primary and recurrent coronary heart disease (CHD) events in the placebo arms of the clinical trials, and that this increased risk is virtually eliminated with statin therapy.

26 Mar 2010

Budget continues to ignore mental illness and sanctions deaths of young Ontarians

Suicide is the leading cause of non-accidental death in Ontario's youths aged 10 to 19, claiming the lives of our young people more than any other health-related cause. Mental illness is the strongest risk factor for suicide yet these youths cannot get treatment because of years of government underfunding.

26 Mar 2010

Substance abuse treatment services: Routine on-site infectious disease screening necessary

Fewer than half of all substance abuse treatment facilities surveyed nationwide reported that they conduct on-site infectious disease screening, according to a new study sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA).

26 Mar 2010

Researchers made vital discovery in the development of new drug to cure TB

This World TB Day (March 24), researchers at Sydney's Centenary Institute announce they have made an exciting discovery that could lead to the first new drug for Tuberculosis (TB) in almost fifty years.

26 Mar 2010

TechTeam Global renews contract with American Community Mutual Insurance Company

TechTeam Global, Inc.,, a worldwide provider of information technology outsourcing and business process outsourcing services, announced today that it has renewed its contract with American Community Mutual Insurance Company (American Community) to provide a broad range of IT infrastructure outsourcing services.

26 Mar 2010

Medical News

Survival rate is improving in HER2 positive breast cancer patients

U.S. DEA rules prevent nursing home patients in severe pain from receiving needed medication

OHA expresses strong support for creation of committee to address hospital working capital deficits

Abnormality on chromosome 17 helps detect breast cancer tumour's response to anthracyclines

Treatment with beta-blockers can help reduce spread of cancer in patients with breast tumours

Avid, Cardinal Health partner to detect Alzheimer's disease in living patients

American Academy of Actuaries to work with regulatory authorities to enhance quality of care

Evaluating potential of Ampligen and TLR3 agonists as cancer immunotherapeutics

FDA Advisory Committee to review VIVUS' NDA for Qnexa

Alere WCH partners with Monica Healthcare

BLS acquires AMPAKINE compounds from Cortex Pharmaceuticals

New devices pave way for applications in cardiology and neurology

Pravastatin benefits elderly carriers of KIF6 gene variant with prior vascular disease

Budget continues to ignore mental illness and sanctions deaths of young Ontarians

Substance abuse treatment services: Routine on-site infectious disease screening necessary

Researchers made vital discovery in the development of new drug to cure TB

TechTeam Global renews contract with American Community Mutual Insurance Company

Lung transplant patients may one day benefit from synthetic peptide, researchers report

UK government commits £250M for proposed medical research and innovation centre

Secretary of Veterans Affairs to kick off National Disabled Veterans Winter Sports Clinic in Colorado

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News